Donnatal (RxPak Division of McKesson Corporation)
Welcome to the PulseAid listing for the Donnatal drug offered from RxPak Division of McKesson Corporation. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | RxPak Division of McKesson Corporation |
NON-PROPRIETARY NAME: | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE |
SUBSTANCE NAME: | PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2014-05-26 |
END MARKETING DATE: | 0000-00-00 |
Donnatal HUMAN PRESCRIPTION DRUG Details:
Item Description | Donnatal from RxPak Division of McKesson Corporation |
LABELER NAME: | RxPak Division of McKesson Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 16.2; .1037; .0194; .0065(mg/1; mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2014-05-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65084-123_0f4e771f-b317-4220-8391-dfcfb83bd479 |
PRODUCT NDC: | 65084-123 |
APPLICATION NUMBER: | |
Other PHENOBARBITAL; HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: